Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 62 Records) |
| Query Trace: Hepatitis A and F3[original query] |
|---|
| The absence of the human platelet antigen polymorphism effect on fibrosis progression in human immunodeficiency virus-1/hepatitis C virus coinfected patients. Revista da Sociedade Brasileira de Medicina Tropical 2015 Aug 48 (4): 406-9. Picelli Natália, Tanikawa Aline Aki, Grotto Rejane Maria Tommasini, Silva Giovanni Faria, Barbosa Alexandre Naime, Ferrasi Adriana Camargo, Silveira Liciana Vaz de Arruda, Pardini Maria Inês de Moura Camp |
| Glutathione S-Transferase M1 and T1 Gene Polymorphisms and the Outcome of Chronic Hepatitis C Virus Infection in Egyptian Patients. Annals of human genetics 2015 Nov . Ibrahim Amany M, Ahmed Hanan S, Alazizi Nashwa M, Mansour Marwa A, Mansour Shymaa |
| CD36 genetic variation, fat intake and liver fibrosis in chronic hepatitis C virus infection. World journal of hepatology 2016 Sep 8 (25): 1067-74. Ramos-Lopez Omar, Roman Sonia, Martinez-Lopez Erika, Fierro Nora A, Gonzalez-Aldaco Karina, Jose-Abrego Alexis, Panduro Artu |
| Genetic diversity of hepatitis B virus and mutations associated to hepatocellular carcinoma in patients from Venezuela, with different stages of liver disease. Investigacio?n cli?nica 2016 Mar 57 (1): 38-46. Puche Mary L, Kay-Valero Sharon, Michelli Pedro, Oropeza Maria D, Loureiro Carmen L, Devesa Marisol, Dagher Lucy, Puol Flor |
| Rate and predictors of treatment failure to all-oral HCV regimens outside clinical trials. Antiviral therapy 2016 Jun . Arias Ana, Aguilera Antonio, Soriano Vicente, Benítez-Gutiérrez Laura, Lledó Gemma, Navarro Daniel, Treviño Ana, Otero Esteban, Peña José M, Cuervas-Mons Valentín, de Mendoza Carm |
| Low Molecular Mass Polypeptide 7 Single Nucleotide Polymorphism is Associated with the Progression of Liver Fibrosis in Patients Infected with Hepatitis C Virus Genotype 4. Clinical laboratory 2016 62 (3): 381-7. El Awady Mostafa K, Omran Moataza H, Ibrahim Marwa K, Moustafa Amr M, Dawood Reham M, Bader El Din Noha G, Elsharkawy Aisha, Abdel Aziz Mohamad S, El Shenawy Reem, El Abd Yasmine S, Abdel Aziz Ashraf |
| GC Gene Polymorphism and Unbound Serum Retinol-Binding Protein 4 Are Related to the Risk of Insulin Resistance in Patients With Chronic Hepatitis C: A Prospective Cross-Sectional Study. Medicine 2016 Mar 95 (10): e3019. Mateos-Muñoz Beatriz, García-Martín Elena, Torrejón María J, Devesa-Medina María J, Esguevillas Gara, Cárdenas María C, Fernández Cristina, Carballo Miguel, Agúndez José A, Ladero José |
| Real-world effectiveness of peginterferon a-2b plus ribavirin in a Canadian cohort of treatment-naïve chronic hepatitis C patients with genotypes 2 or 3: results of the PoWer and RediPEN studies. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2016 Feb . Marotta P, Bailey R, Elkashab M, Farley J, Feinman S V, Peltekian K, Poliquin M, Witt-Sullivan H, Rampakakis E, Drolet M, Cooper |
| IL15 polymorphism is associated with advanced fibrosis, inflammation-related biomarkers and virological response in human immunodeficiency virus/hepatitis C virus coinfection. Liver international : official journal of the International Association for the Study of the Liver 2016 Feb . Jiménez-Sousa María A, Berenguer Juan, Rallón Norma, Pineda-Tenor Daniel, Echevarria Teresa Aldamiz-, Soriano Vicente, García-Álvarez Mónica, Vazquez-Morón Sonia, Restrepo Clara, Carrero Ana, Benito José Miguel, Resino Salvad |
| Different precore/core mutations of hepatitis B interact with, limit, or favor liver fibrosis severity. Journal of gastroenterology and hepatology 2016 Mar . Ducancelle Alexandra, Pivert Adeline, Bertrais Sandrine, Boursier Jérôme, Balan Viorica, Veillon Pascal, le Guillou-Guillemette Hélène, Thibault Vincent, Castelain Sandrine, Roquebert Bénédicte, Coste-Burel Marianne, Mackiewicz Vincent, Schvoerer Evelyne, Larrat Sylvie, Maylin Sarah, Alain Sophie, Loustaud-Ratti Véronique, Gordien Emmanuel, Gozlan Joël, Brodard Véronique, Chevaliez Stéphane, Calès Paul, Lunel-Fabiani Françoi |
| Sofosbuvir plus ledispasvir for recurrent hepatitis C in liver transplant recipients. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2016 Aug . Kwok Ryan M, Ahn Joseph, Schiano Thomas D, Te Helen S, Potosky Darryn R, Tierney Amber, Satoskar Rohit, Robertazzi Suzanne, Rodigas Colleen, Lee Sang Michelle, Wiegel Joshua, Patel Neal, Gripshover Janet, Hassan Mohamed A, Branch Andrea, Smith Coleman |
| Effect of Vitamin D Serum Levels and GC Gene Polymorphisms in Liver Fibrosis Due to Chronic Hepatitis C. Annals of hepatology 2017 Aug 16 (5): 742-748. Azevedo Laura A, Matte Ursula, Silveira Themis R, Bonfanti Jacqueline W, Bruch Juliana P, Álvares-da-Silva Mário |
| Interferon lambda 4 rs368234815 TT>?G variant is associated with liver damage in patients with nonalcoholic fatty liver disease. Hepatology (Baltimore, Md.) 2017 Jul . Petta Salvatore, Valenti Luca, Tuttolomondo Antonino, Dongiovanni Paola, Pipitone Rosaria Maria, Cammà Calogero, Cabibi Daniela, Di Marco Vito, Fracanzani Anna Ludovica, Badiali Sara, Nobili Valerio, Fargion Silvia, Grimaudo Stefania, Craxì Anton |
| Diversity of the association of serum levels and genetic variants of MHC class I polypeptide-related chain A with liver fibrosis in chronic hepatitis C. Oncotarget 2017 Mar . Huang Chung-Feng, Huang Ching-I, Yeh Ming-Lun, Wang Shu-Chi, Chen Kuan-Yu, Ko Yu-Min, Lin Ching-Chih, Tsai Yi-Shan, Tsai Pei-Chien, Lin Zu-Yau, Chen Shinn-Cherng, Dai Chia-Yen, Huang Jee-Fu, Chuang Wan-Long, Yu Ming-Lu |
| Association of Serum Lipids with Hepatic Steatosis, Stage of Liver Fibrosis and Viral Load in Chronic Hepatitis C. Journal of clinical and diagnostic research : JCDR 2017 10 11 (8): OC15-OC20. Valkov Ivan, Ivanova Radina, Alexiev Assen, Antonov Krasimir, Mateva Lyudmi |
| Sofosbuvir-based treatment regimens: real life results of 14 409 chronic HCV genotype 4 patients in Egypt. Alimentary pharmacology & therapeutics 2017 1 45 (5): 681-687. Elsharkawy A, Fouad R, El Akel W, El Raziky M, Hassany M, Shiha G, Said M, Motawea I, El Demerdash T, Seif S, Gaballah A, El Shazly Y, Makhlouf M A M, Waked I, Abdelaziz A O, Yosry A, El Serafy M, Thursz M, Doss W, Esmat |
| Two sides of a coin: GG genotype of C7 provides protection against fibrosis severity while showing a higher risk for hepatocellular carcinoma in patients with hepatitis C. Human immunology 2018 Jun . de Lima Raul Emídio, de Holanda Martins Cyntia Maria, do Carmo Rodrigo Feliciano, Aroucha Dayse Celia Barbosa Lins, Pereira Leila Maria Moreira Beltrão, Vasconcelos Luydson Richardson Silva, Moura Patríc |
| Diagnosis of cirrhosis in patients with chronic hepatitis C genotype 4: Role of ABCB11 genotype polymorphism and plasma bile acid levels. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 2018 May 29 (3): 299-307. Besheer Tarek, Arafa Mona, El-Maksoud Mohamed Abd, Elalfy Hatem, Hasson Amany, Zalata Khaled, Elkashef Wagdi, Elshahawy Heba, Raafat Doaa, Elemshaty Wafaa, Elsayed Eman, Zaghloul Hosam, Razek Ahmed Abdel, El-Bendary Mahmo |
| Clinical Evaluation of Hepatocarcinogenesis and Outcome Using a Novel Glycobiomarker Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein (WFA-M2BP) in Chronic Hepatitis C with Advanced Fibrosis. Japanese journal of infectious diseases 2018 3 71 (3): 177-183. Inoue Takako, Tsuzuki Yuji, Iio Etsuko, Shinkai Noboru, Matsunami Kayoko, Fujiwara Kei, Matsuura Kentaro, Nojiri Shunsuke, Tanaka Yasuhi |
| [Interferon Lambda 4 RS12979860 C>T polymorphism is not associated with liver fibrosis in patients with hepatitis C]. Revista medica de Chile 2018 Jul 146 (7): 823-829. Brahm Javier, Urzúa Alvaro, Poniachik Jaime, Cáceres Dante D, Carreño Laura, Venegas Mauric |
| Human platelet antigens polymorphisms; association to the development of liver fibrosis in patients with chronic hepatitis C. Journal of medical virology 2019 Feb . Ghasemi Ali, Zadsar Maryam, Shaiegan Mojgan, Samiei Shahram, Namvar Ali, Rasouli Mahboobeh, Moosanejad Molo |
| Interleukin 28 Polymorphisms and Hepatocellular Carcinoma Development after Direct Acting Antiviral Therapy for Chronic Hepatitis C. Journal of gastrointestinal and liver diseases : JGLD 2019 Dec 28 (4): 449-456. Simili Angelo, Mazzella Giuseppe, Ravaioli Federico, Festi Davide, Bacchi-Reggiani Maria Letizia, Porro Alberto, Bazzoli Franco, Azzaroli Frances |
| Efficacy and safety of elbasvir/grazoprevir for 8 or 12 weeks for hepatitis C virus genotype 4 infection: A randomized study. Liver international : official journal of the International Association for the Study of the Liver 2019 11 40 (5): 1042-1051. Asselah Tarik, Pol Stanislas, Hezode Christophe, Loustaud-Ratti Veronique, Leroy Vincent, Ahmed Si Nafa Si, Ozenne Violaine, Bronowicki Jean-Pierre, Larrey Dominique, Tran Albert, Alric Laurent, Nguyen-Khac Eric, Robertson Michael N, Hanna George J, Brown Deborah, Asante-Appiah Ernest, Su Feng-Hsiu, Hwang Peggy, Hall Jessie Durrand, Guidoum Amir, Hagen Karin, Haber Barbara A, Talwani Rohit, Serfaty Lawren |
| Clinical and histopathological changes in different KIR gene profiles in chronic HCV Romanian patients. International journal of immunogenetics 2020 9 48 (1): 16-24. Ursu Larisa Denisa, Calenic Bogdan, Diculescu Mircea, Dima Alina, Stoian Iulia Teodora, Constantinescu Ilea |
| Efficacy and safety of glecaprevir/pibrentasvir in treatment-naïve adults with chronic hepatitis C virus genotypes 1-6 in Brazil. Annals of hepatology 2020 Sep . Peribañez-Gonzalez Mario, Cheinquer Hugo, Rodrigues Lino, Lima Maria Patelli, Álvares-da-Silva Mário Reis, Madruga José, Parise Edison Roberto, Pessoa Mário Guimarães, Furtado Juvencio, Villanova Marcia, Ferreira Adalgisa, Mazzoleni Felipe, Nascimento Ecio, Silva Giovanni Faria, Fredrick Linda, Krishnan Preethi, Burroughs Margaret, Reuter Tan |
| Effectiveness and safety of sofosbuvir/velpatasvir ± ribavirin vs glecaprevir/pibrentasvir in genotype 3 hepatitis C virus infected patients. European journal of hospital pharmacy : science and practice 2020 4 27 (e1): e41-e47. Margusino-Framiñán Luis, Cid-Silva Purificación, Rotea-Salvo Sandra, Mena-de-Cea Álvaro, Suárez-López Francisco, Vázquez-Rodríguez Pilar, Delgado-Blanco Manuel, Sanclaudio-Luhia Ana Isabel, Martín-Herranz Isabel, Castro-Iglesias Ángel |
| Single nucleotide polymorphisms in PNPLA3, ADAR-1 and IFIH1 are associated with advanced liver fibrosis in patients co-infected with HIV-1//hepatitis C virus. AIDS (London, England) 2021 9 35 (15): 2497-2502. Franco Sandra, Horneros Judith, Soldevila Laura, Ouchi Dan, Galván-Femenía Iván, de Cid Rafael, Tenesa Montserrat, Bechini Jordi, Perez Ricardo, Llibre Josep M, Clotet Bonaventura, Tural Cristina, Martínez Miguel Ang |
| Evaluation of the association of a variant in PNPLA3 and TM6SF2 with fibrosis progression in patients with chronic hepatitis C infection after eradication: A retrospective study. Gene 2022 Feb 820 146235. Kang Qian, Xu Jinghang, Luo Hao, Tan Ning, Chen Hongyu, Cheng Ran, Pan Jiali, Han Yifan, Yang Yuqing, Liu Dan, Xi Hongli, Yu Min, Xu Xiaoyu |
| Liver Fibrosis Regression and Associated Factors in HCV Patients Treated with Direct-Acting Antiviral Agents. Life (Basel, Switzerland) 2023 9 13 (9): . Naim Abu-Freha, Osama Abu-Kosh, David Yardeni, Yaffa Ashur, Muhammad Abu-Arar, Baha Yousef, Shulamit Monitin, Sarah Weissmann, Ohad Etzi |
| Role of Inflammatory/Immune Response and Cytokine Polymorphisms in the Severity of Chronic Hepatitis C (CHC) before and after Direct Acting Antiviral (DAAs) Treatment. International journal of molecular sciences 2023 1 24 (2): . Ferreira Joana, Oliveira Mariana, Bicho Manuel, Serejo Fáti |
- Page last reviewed:Feb 1, 2024
- Content source: